PROBLEM: 80% of Ovarian Cancer is Fatal

VesiCure's 
Solution:

Macrophage Engineered Vesicles (MEVs): The Only Effective Maintenance Therapy
MEVs are a cell-based therapy for ovarian cancer maintenance treatment.

FEATURES

MEVs are a cell-based therapy for ovarian cancer maintenance treatment

EFFECTIVE

Impressive anti-cancer activity

SAFE

No serious adverse effects

UNMET MEDICAL NEED

No serious adverse effects

PERSONALIZED

Autologous

CURRENT APPROVED OVARIAN CANCER MAINTENANCE THERAPIES

VESICURE: VALUE PROPOSITION

HEALTH CARE PROVIDERS

Improves patient outcomes

Doesn’t compete with
other modalities

HEALTH SYSTEMS

Generates outpatient revenue

Integrates into existing workflow

WOMEN WITH OVARIAN CANCER

Improved survival

No adverse effects